Drug metabolizing activity in chronic liver disease was examined. In 53 patients with chronic liver disease, 7-methoxycoumarin (7-MC) 0-demethylase and 7-ethoxycoumarin 
Introduction
The liver is the major site of drug metabolism. Many hydrophobic compounds, including drugs, chemicals, environmental pollutants and carcinogens, are biotransformed into more hydrophilic metabolites in liver microsomes. In rats with chronic liver injury induced by carbon tetrachloride (CC14) 1) and a choline-deficient diet2) , the drug metabolizing activity in liver microsomes is known to be impaired with progressive histological impairment of the S -116 liver.
On the other hand, the drug metabolizing activity in patients with chronic liver disease has been investigated mainly by means of the elimination half-lives of several drugs, such as theophylline3, 4) and antipyrine5) , which are chiefly metabolized in the liver. The drug metabolizing activity in human liver microsomes has been reported using specimens obtained by autopsy'', 7) and during operations8' 9) ; however, there have been few reports involving specimens obtained by liver biopsy10- 13) In recent years, ultrasonically-guided (US-guided) needle biopsy has been widely used in Japan because of its safety and simplicity ; it has been reported that 7-alkoxycoumarin 0-dealkylase activities can be measured using 10 mg of a liver specimen".
In the present study, 7-methoxycoumarin (7-MC) 0-demethylase and 7-ethoxycoumarin (7-EC) 0-deethylase activities in the liver obtained by US-guided biopsy were measured in patients with a variety of chronic liver diseases and compared with the degree of histological impairment of the liver. The elimination half-life (T1/2) of theophylline and biochemical liver function tests were also investigated in each patient and compared with the drug metabolizing activity in the liver.
Materials and Methods

Subjects
US-guided liver biopsy by a fine needle was performed on a total of 53 patients with chronic liver disease. The patients consisted of 20 females and 33 males and their average age was 48. 1 years old. A part of the liver tissue obtained was used for the assay of drug metabolizing activity and the remains were fixed in formalin for histological examination.
Informed consent had been obtained from each patient.
The degrees of histological impairment of the liver were classified into four grades according to the classification by the European Association for the Study of the Liver (1968) 15)
12 patients with chronic persistent hepatitis (CPH), 11 patients with chronic aggressive hepatitis (moderate) (CAH 2A) , 8 patients with chronic aggressive hepatitis (severe) (CAH 2B) and 20 patients with liver cirrhosis (LC) . In two patients, histological findings of the liver were revealed to be normal : a patient with elevated serum transaminases who was finally diagnosed as polymyositis, and a patient on whom liver biopsy was performed in order to deny a liver tumor.
None had significant cardiac decompensation and renal functions of all the patients were normal. Some of the patients were taking drugs, such as furosemide, but none was receiving compounds known to induce or reduce the activity of drug metabolizing enzymes. Heavy S -117 smokers (over 1 pack per day) and patients with obvious alcoholic liver disease were excluded.
Assays of drug metabolizing activity in the liver
A piece (about 10 mg wet weight) of the liver tissue was immediately homogenized in O. 8 ml of 20 mM potassium phosphate buffer (pH 7. 4) containing 15% glycerol at 0-4°C.
7-MC 0-demethylase and 7-EC 0-deethyiase activities were determined by a direct fluorometric measurement of 7-hydroxycoumarin produced according to the method of Ullrich and
Weber' 6' . The substrates, 7-EC and 7-MC, were dissolved in 1 M Tris-HC1 buffer (pH Table 1 .
The mean value of the two patients with normal livers were taken as the control (100%) .
The 7-MC 0-demethylase activities in patients with CPH, CAH 2A, CAH 2B and LC were As shown in Fig. 3 , the theophylline T1/2 in patients with normal liver was 5. 9 ± 2. 0 hr; those in patients with CPH, CAH 2A, CAH 2B and LC were gradually prolonged to 5. 9 ± 1. 4, 7. 3 ± 2. 0, 9. 9 ± 3. 3 and 17. 3 ± 6. 7 hr, respectively. No significant difference was observed among patients with normal liver, CPH and CAH 2A. The theophylline T1/2 in patients with CAH 2B was significantly longer than that in patients with CPH, but no significant difference was observed between patients with CAH 2A and CAH 2B. In patients with LC, the theophylline T1/2 was markedly prolonged and significantly different from any other group. Relationship between drug metabolizing activity in the liver and biochemical liver function tests
There were no significant correlations between the 7-MC 0-demethylase activity in the liver and serum GPT or LAP, and weak correlations were observed between this enzyme activity and GOT or ALP (Fig. 5) . In contrast, fair correlations were observed between the 7-MC 0-demethylase activity in the liver and Alb, ChE, PT or HPT with coefficient values of 0. 565, 0. 657, 0. 520 and 0. 621, respectively (Fig. 6 ). There was no significant correlation between the 7-MC 0-demethylase activity in the liver and T-Chol, but fair correlations were observed between this enzyme activity and E/T, ZTT or BCAA/AAA with coefficient values of 0. 642, -0. 618 and 0. 637, respectively (Fig. 7) . On the other hand, there were good logarithmic correlations between the 7-MC 0-demethylase activity in the liver and ICGR15 or KICG with coefficient values of -0. 700 and 0. 759, respectively (Fig. 8 ) .
As shown in Table 2 , a similar tendency was observed concerning the relationships between the 7-EC 0-deethylase activity in the liver and the liver function tests investigated ; the correlation coefficients, however, were slightly smaller than those of the 7-MC 0-demethylase activity in the liver. 
S -126 Discussion
Many investigators have reported in vivo studies in which the elimination of drugs metabolized in the liver was impaired in chronic liver disease3-5) . Since the rate of drug elimination from the blood is dependent not only on drug metabolizing enzymes in the liver but also on other factors, such as blood flow, binding to plasma proteins and liver size, the investigation of drug metabolizing activity in liver microsomes and a comparison with drug elimination in vivo are also important for estimating drug metabolizing activity in chronic liver disease.
In this study, both the 0-dealkylase activities toward 7-MC and 7-EC per g liver were gradually decreased with progressive histological impairment of the liver ; especially, the activities in patients with CAH 2B and LC were obviously lower than those in patients with CPH. Schoene et al. 1°) reported similar results in which the content of cytochrome P-450
(P-450) , and aminopyrine N-demethylase and p-nitroanisole 0-demethylase activities in the liver were lowered only in severe hepatitis and LC. Kratz11) also demonstrated that in patients with LC, chronic fatty (alcoholic) hepatitis and CAH, coumarin-7-hydroxylase activity in the liver was significantly lower, but there was no significant difference between patients with subacute viral hepatitis or CPH and normal controls. However, neither study referred to drug elimination in vivo. On the other hand, some investigators have reported that drug metabolizing activity in the liver was enhanced in chronic alcoholic liver damage", 19) ; in this study, patients with obvious alcoholic liver disease were excluded.
In these experiments, drug metabolizing activity in the liver was expressed per g liver, so
that the decreases in the 0-dealkylase activities toward 7-MC and 7-EC, especially in patients with CAH 2B and LC, may have reflected the relative decrease in the number of liver cells following the development of hepatic fibrosis as well as the reduction in the function of individual liver cells. In fact, in rats with chronic liver injury induced by CCl4, the content of P-450 and four substrate-metabolizing activities per g liver were reported to be 5-10% lower than those per mg microsomal protein'. There are two reasons why drug metabolizing activity in the liver were expressed per g liver in these experiments. First, the preparation of microsomes from a small amount of specimen obtained by liver biopsy is difficult by routine methods ; 0-dealkylase activities toward 7-MC and 7-EC can be measured using not only liver microsomes but also whole liver homogenates, as Matsubara et al. 2°) already reported. Secondly, the drug metabolizing activity expressed per g liver is considered
to be clinically more benefical than that of individual liver cells ; for example, if a liver volume can be determined by imaging techniques, the drug metabolizing activity of the total liver can be calculated from that per g liver.
S -127
13-450, which is a key enzyme in the mixed-function oxidase system in liver microsomes, consists of multiple species", 2 2) ; various physiological and pathological conditions affect the population of P-450 species. It was reported that some type (s) of P-450 species may have been selectively reduced in rats with chronic liver injury induced by CC141) and a choline-deficient diet2) . Recently, Okuno et al. 14) demonstrated that the ratios of 7-EC 0-deethylase and 7-propoxycoumarin (7-PC) 0-depropylase to 7-MC 0-demethylase activity in rats treated with six inducers were clearly different from each other. They emphasized that the measurement of 7-alkoxycoumarin 0-dealkylase activities should be extremely useful for the routine determination of the molecular species of P-450. Kasahara et al. 2 3) investigated the effects of D-galactosamine and CC14 on 7-alkoxycoumarin 0-dealkylase activities in rat liver microsomes. They reported that the ratio of 7-EC 0-deethylase and 7-PC 0-depropylase to 7-MC 0-demethylase activity was not altered by D-galactosamine treatment, but decreased with CC14 treatment, although all these activities were reduced by either treatment.
In this study, both the 0-dealkylase activities toward 7-MC and 7-EC were gradually decreased to similar extents with progressive histological impairment of the liver.
However, the ratio of 7-EC 0-deethylase to 7-MC 0-demethylase activity in patients with LC was slightly but significantly different from those in patients with CPH and CAH 2A, so that there might be a possibility that some type (s) of P-450 species was selectively altered in human LC. Farrell et al. 13) demonstrated that aryl hydrocarbon hydroxylase activity was lower in patients with severe hepatitis or active cirrhosis than in controls, but ethylmorphine demethylase activity was unchanged in the patients, and proposed the heterogeneity of P-450 species affected by human liver disease. Their report supports the observations in this study.
Theophylline is known to be metabolized chiefly in the liver. Its elimination from the blood is dependent mainly on drug metabolizing activity in liver microsomes; other factors such as Moreover, since this method requires only a small amount (about 10 mg) of liver specimen, it is possible to determine both the activity of drug metabolizing enzymes and hepatic histology with the same specimen. As was confirmed in this study, the activity of drug metabolizing enzymes in the liver reflect hepatic functional capacity ; therefore, the measurement of drug metabolizing activity in specimens obtained by liver biopsy is extremely useful for the clinical estimation of liver cell functions.
